Co-creating tools for embedding meaningful patient and public involvement and engagement in real-world data and evidence research in the pharmaceutical industry setting: a multistakeholder participatory co-design study
To our knowledge, this is the first project to explore the practicalities of PPIE in RWDE research from the perspective of patients and carers. Some findings confirm PPIE experience and guidance derived from other areas, with some specific insights into the pharmaceutical industry. These underpin the PPIE framework to enable robust and meaningful PPIE in RWDE research. This article includes a plain language summary in the supplement.
Authors
- Sally-Anne Dews (ORCID: https://orcid.org/0000-0003-0941-5379)
- Susan Moloney (ORCID: https://orcid.org/0000-0003-2877-692X)
- Mary Araghi
- Rebecca Butfield (ORCID: https://orcid.org/0009-0005-8521-1863)
- Viola Wontor
- Alexia Campbell Burton
- Lynne Corner (ORCID: https://orcid.org/0000-0002-6806-0304)
- Hannah Monelle
- Polly Westergaard
Institutions
- Pfizer (United Kingdom) (GB)
- Newcastle University (GB)
Publication Details
- Journal
- BMJ Open
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1136/bmjopen-2024-088914
- Citations
- 2
- Primary Topic
- Mental Health and Patient Involvement
- Type
- article
- Field-Weighted Citation Impact
- 5.63
Funders
- Pfizer
- Pfizer UK